Skip to main content

Table 2 Functional and anatomical results in the whole series and in the 2 subgroups

From: Short-term efficacy of intravitreal Aflibercept injections for retinal angiomatous proliferation

  

Baseline

(mean ± SD)

Post-Tx

(mean ± SD)

P = a

Whole Series

BCVA (logMAR)

1.23 ± 0.56

0.87 ± 0.41

0.014

(n = 19)

CRT (μm)

404.0 ± 131.7

306.1 ± 112.0

0.0002

Subgroups

   

Naïve Group

BCVA (logMAR)

1.32 ± 0.58

0.92 ± 0.47

0.047

(n = 11)

CRT (μm)

436.6 ± 96.6

298.6 ± 87.3

0.003

Pretreatment Group

BCVA (logMAR)

1.09 ± 0.54

0.78 ± 0.33

0.173

(n = 8)

CRT (μm)

359.1 ± 165.2

316.5 ± 145.4

0.018

  1. BCVA best-corrected visual acuity, CRT central retinal thickness, LogMAR logarithm of the minimum angle of resolution, Post-Tx post-treatment, SD Standard deviation
  2. aWilcoxon Signed Ranks Test (2-tailed)